A dedicated venture capital investment platform driving health care innovation and digital disruption forward.

CVS Health Ventures

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

AmerisourceBergen Corporation

PlayCore builds recreation environments and offers products for promoting active and healthy lifestyles, self-described as a purpose-driven health and wellness-focused company.

PlayCore

Vitae Health Systems provides multi-specialty healthcare solutions through full-time clinicians who integrate into healthcare facilities' disciplinary teams

Metric
Company Name	CVS Health Ventures	AmerisourceBergen Corporation	PlayCore	Vitae Health Systems
Symbol		ABC
MSH ID	COM:CVSHEALTHVENTURES	COM:AMERISOURCEBERGEN	COM:PLAYCORE	COM:VITAEHS
Market	PRIVATE	STOCKS	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Healthcare	Consumer Goods	Healthcare & Health Services
Industry	Venture Capital	Medical - Distribution	Recreation Products	Healthcare Staffing and Services
Country	US	US	US	US
Stage
Employee Count		46K
Website	cvshealthventures.com	amerisourcebergen.com	playcore.com	vitaehs.com
LinkedIn
Founders

Metric
Market Cap	36.15B
Enterprise Value
Monthly Web Traffic		16.33K
Web Traffic Growth		-0.19
Valuation
Raised Capital

Metric
Revenue		293.96B
Revenue (LTM)
Revenue (NTM)
Gross Profit		9.91B
EBITDA		3.24B
Operating Income		2.18B
Net Income		1.51B
EPS		7.60
Diluted EPS		7.53
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.03
Operating Profit Margin		0.01
EBITDA Margin		0.01
Net Profit Margin		0.01
Return on Equity		2.48
Return on Assets		0.03
Return on Capital Employed		0.20

CVSH

COM:CVSHEALTHVENTURES

CVS Health Ventures

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		21.56
P/B Ratio		39.50
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		0.17
EV Multiple		11.87

Metric
Days Sales Outstanding		29.83
Days Payables Outstanding		64.99
Days Inventory Outstanding		25.96
Operating Cycle		55.56
Cash Conversion Cycle		-7.62
Asset Turnover		4.33

Metric
Operating Cash Flow		3.48B
Free Cash Flow		3.00B
Cash Flow to Debt		0.91
Operating Cash Flow/Sales		0.02
Free Cash Flow Yield		0.08

Metric
Cash & Equivalents		3.13B
Accounts Receivable		-2.78B
Inventory		20.17B
Goodwill
Debt to Capitalization		0.84
Debt to Assets		0.08
Current Ratio		0.88
Quick Ratio		0.55

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.00
R&D to Revenue
SG&A to Revenue